HomeNewsBusinessExpect economy to bounce back once COVID-19 brought under control: India Cements

Expect economy to bounce back once COVID-19 brought under control: India Cements

Company Managing Director and noted industrialist N Srinivasan told reporters that the COVID-19 factor has resulted in the cement industry seeing a 25 percent decline in March compared to last year, while capacity utilisation for the sector, as well as the company, was below normal levels.

June 24, 2020 / 21:26 IST
Story continues below Advertisement

India Cements on Wednesday said that it expects the economy, driven by high domestic consumption and a strong rural base, to bounce back once the COVID-19 pandemic is brought under control.

Company Managing Director and noted industrialist N Srinivasan told reporters that the COVID-19 factor has resulted in the cement industry seeing a 25 percent decline in March compared to last year, while capacity utilisation for the sector, as well as the company, was below normal levels.

Story continues below Advertisement

The city-headquartered company commenced operations in April following the partial lifting of the nationwide COVID-19 enforced lockdown.

However, with the re-introduction of lock-down in certain parts of the state due to the rising COVID-19 cases, it was difficult to predict economic growth in the coming two quarters, he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show